Search Results - "KARANAM, Bindhu V"
-
1
Antidiabetic and antisteatotic effects of the selective fatty acid synthase (FAS) inhibitor platensimycin in mouse models of diabetes
Published in Proceedings of the National Academy of Sciences - PNAS (29-03-2011)“…Platensimycin (PTM) is a recently discovered broad-spectrum antibiotic produced by Streptomyces platensis. It acts by selectively inhibiting the…”
Get full text
Journal Article -
2
Identification and characterization of sebaceous gland atrophy-sparing DGAT1 inhibitors
Published in PloS one (18-02-2014)“…Inhibition of Diacylglycerol O-acyltransferase 1 (DGAT1) has been a mechanism of interest for metabolic disorders. DGAT1 inhibition has been shown to be a key…”
Get full text
Journal Article -
3
Discovery of MK-1421, a Potent, Selective sstr3 Antagonist, as a Development Candidate for Type 2 Diabetes
Published in ACS medicinal chemistry letters (14-05-2015)“…The imidazolyl-tetrahydro-β-carboline class of sstr3 antagonists have demonstrated efficacy in a murine model of glucose excursion and may have potential as a…”
Get full text
Journal Article -
4
Mechanistic Studies on the Metabolic Scission of Thiazolidinedione Derivatives to Acyclic Thiols
Published in Chemical research in toxicology (01-05-2005)“…Thiazolidinedione (TZD) derivatives have been reported to undergo metabolic activation of the TZD ring to produce reactive intermediates. In the case of…”
Get full text
Journal Article -
5
SPECIES DIFFERENTIAL STEREOSELECTIVE OXIDATION OF A METHYLSULFIDE METABOLITE OF MK-0767 [(±)-5-[(2,4-DIOXOTHIAZOLIDIN-5-YL)METHYL]-2-METHOXY-N-[[(4-TRIFLUOROMETHYL)PHENYL]METHYL]BENZAMIDE], A PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR DUAL AGONIST
Published in Drug metabolism and disposition (01-10-2004)“…MK-0767 [(±)-5-[(2,4-dioxothiazolidin-5-yl)methyl]-2-methoxy- N -[[(4-trifluoromethyl)phenyl]methyl]benzamide], a thiazolidinedione (TZD)-containing…”
Get full text
Journal Article -
6
Accelerating the discovery of DGAT1 inhibitors through the application of parallel medicinal chemistry (PMC)
Published in Bioorganic & medicinal chemistry letters (01-06-2019)“…[Display omitted] The parallel medicinal chemistry (PMC) was effectively applied to accelerate the optimization of diacylglycerol O-acyltransferase I (DGAT-1)…”
Get full text
Journal Article -
7
Benzimidazole-based DGAT1 inhibitors with a [3.1.0] bicyclohexane carboxylic acid moiety
Published in Bioorganic & medicinal chemistry letters (15-05-2019)“…Previously disclosed benzimidazole-based DGAT1 inhibitors containing a cyclohexane carboxylic acid moiety suffer from isomerization at the alpha position of…”
Get full text
Journal Article -
8
IDENTIFICATION AND METABOLISM OF A NOVEL DIHYDROHYDROXY-S-GLUTATHIONYL CONJUGATE OF A PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR AGONIST, MK-0767 [(±)-5-[(2,4-DIOXOTHIAZOLIDIN-5-YL)METHYL]-2-METHOXY-N-[[(4-TRIFLUOROMETHYL) PHENYL]METHYL]BENZAMIDE], IN RATS
Published in Drug metabolism and disposition (01-10-2004)“…MK-0767 [(±)-5-[(2,4-dioxothiazolidin-5-yl)methyl]-2-methoxy- N -[[(4-trifluoromethyl)phenyl]methyl]benzamide] is a novel thiazolidinedione-containing…”
Get full text
Journal Article -
9
A novel benzazepinone sodium channel blocker with oral efficacy in a rat model of neuropathic pain
Published in Bioorganic & medicinal chemistry letters (15-06-2013)“…A series of benzazepinones were synthesized and evaluated as Nav1.7 sodium channel blockers. Compound 30 from this series displayed potent channel block, good…”
Get full text
Journal Article -
10
Discovery of a Potent and Selective DGAT1 Inhibitor with a Piperidinyl-oxy-cyclohexanecarboxylic Acid Moiety
Published in ACS medicinal chemistry letters (09-10-2014)“…We report the discovery of a novel series of DGAT1 inhibitors in the benzimidazole class with a piperdinyl-oxy-cyclohexanecarboxylic acid moiety. This novel…”
Get full text
Journal Article -
11
Benzazepinone Nav1.7 blockers : Potential treatments for neuropathic pain
Published in Bioorganic & medicinal chemistry letters (15-11-2007)“…A series of benzazepinones were synthesized and evaluated as hNa(v)1.7 sodium channel blockers. Several compounds from this series displayed good oral…”
Get full text
Journal Article -
12
Imidazopyridines : A novel class of hNav1.7 channel blockers
Published in Bioorganic & medicinal chemistry letters (01-03-2008)“…A series of imidazopyridines were evaluated as potential sodium channel blockers for the treatment of neuropathic pain. Several members were identified with…”
Get full text
Journal Article -
13
Potent DGAT1 Inhibitors in the Benzimidazole Class with a Pyridyl-oxy-cyclohexanecarboxylic Acid Moiety
Published in ACS medicinal chemistry letters (08-08-2013)“…We report the design and synthesis of a series of novel DGAT1 inhibitors in the benzimidazole class with a pyridyl-oxy-cyclohexanecarboxylic acid moiety. In…”
Get full text
Journal Article -
14
Discovery of imidazole carboxamides as potent and selective CCK1R agonists
Published in Bioorganic & medicinal chemistry (01-08-2008)“…The discovery and optimization of a novel class of 1,2-diaryl imidazole carboxamides as CCK1R agonists are reported. Compound 44 exhibited excellent lean mouse…”
Get full text
Journal Article -
15
In vitro metabolism of MK-0767 [(±)-5-[(2,4-dioxothiazolidin-5-yl)methyl]-2-methoxy-N-[[(4-trifluoromethyl)-phe nyl] methyl]benzamide], a peroxisome proliferator-activated receptor α/γ agonist. II. Identification of metabolites by liquid chromatography-tandem mass spectrometry
Published in Drug metabolism and disposition (01-09-2004)“…The in vitro metabolism of MK-0767 [(+/-)-5-[(2,4-dioxothiazolidin-5-yl) methyl]-2-methoxy-N-[[(4-trifluoromethyl)-phenyl] methyl]benzamide], a novel…”
Get full text
Journal Article -
16
In vitro metabolism of MK-0767 [(±)-5-[(2,4-dioxothiazolidin-5-yl)methyl]-2-methoxy-N-[[(4-trifluoromethyl) phenyl]methyl]benzamide], a peroxisome proliferator-activated receptor α/γ agonist. I. Role of cytochrome P450, methyltransferases, flavin monooxygenases, and esterases
Published in Drug metabolism and disposition (01-09-2004)“…The metabolism of MK-0767, (+/-)-5-[(2,4-dioxothiazolidin-5-yl)methyl]-2-methoxy-N-[[(4-trifluoromethyl) phenyl]methyl]benzamide, a thiazolidinedione…”
Get full text
Journal Article -
17
Orally bioavailable, indole-based nonpeptide GnRH receptor antagonists with high potency and functional activity
Published in Bioorganic & medicinal chemistry letters (08-10-2001)“…Stereospecific introduction of a methyl group to the indole-3-side chain enhanced activity in our tryptamine-derived series of GnRH receptor antagonists…”
Get full text
Journal Article -
18
2-Arylindoles as gonadotropin releasing hormone (GnRH) antagonists: optimization of the tryptamine side chain
Published in Bioorganic & medicinal chemistry letters (11-03-2002)“…A series of 2-arylindoles containing novel heteroaromatic substituents on the tryptamine tether, based on compound 1, was prepared and evaluated for their…”
Get full text
Journal Article -
19
In vitro metabolism of FK-506 in rat, rabbit, and human liver microsomes: identification of a major metabolite and of cytochrome P450 3A as the major enzymes responsible for its metabolism
Published in Archives of biochemistry and biophysics (01-05-1992)“…The metabolism of the immunosuppressant FK-506 was shown to be catalyzed primarily by cytochrome P450 isozymes of the P450 3A subfamily. Antibodies against rat…”
Get more information
Journal Article -
20
Imidazopyridines: A novel class of hNav1.7 channel blockers
Published in Bioorganic & medicinal chemistry letters (01-03-2008)Get full text
Journal Article